Press release: May 2, 2022 
              Invitation to the presentation of Elekta’s fiscal year 2021/22 
               
              STOCKHOLM – Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the 
              fiscal year 2021/22 at 10:00 a.m. CEST on May 25. The year-end report will be published at 
              7:30 a.m. CEST on the same day. 
               
              The company’s development will be presented by Elekta’s President and CEO Gustaf Salford 
              together with CFO Tobias Hägglöv. After the presentation, held in English, a Q&A session will 
              follow.  
               
              The presentation will be broadcasted live on the web. It will be necessary to join the phone 
              conference if you plan to ask questions. A recording of the webcast can be found on Elekta’s 
              website after the call. 
               
              Welcome! 
               
              Time: Wednesday, May 25, at 10:00 a.m. CEST 
               
              Telephone numbers to join phone conference: 
              UK: +44 333 300 9266 
              USA: +1 646 722 4903 
              Sweden: +46 8 505 583 73  
               
              Webcast: 
              https://elekta-qreports.creo.se/220525 
               
                                                         # # # 
               
              For further information, please contact: 
              Cecilia Ketels, Head of Investor Relations 
              Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com  
              Time zone: CEST (Central European Summer Time) 
               
              About Elekta 
              As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has 
              access to the best cancer care possible. We openly collaborate with customers to advance 
              sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve 
              lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team 
              of 4,700 employees combine passion, science, and imagination to profoundly change cancer 
              care. We don’t just build technology, we build hope. 
               
              Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and 
              listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on 
              Twitter. 
               
                                          Non-Confidential Information and Basic Personal Data